Total Payments
$10,679
2024 Payments
$1,858
Companies
34
Transactions
271
Medicare Patients
7,067
Medicare Billing
$694,341
Payment Breakdown by Category
Food & Beverage$5,838 (54.7%)
Travel$4,805 (45.0%)
Education$36.20 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,838 | 253 | 54.7% |
| Travel and Lodging | $4,805 | 16 | 45.0% |
| Education | $36.20 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $5,152 | 26 | $0 (2020) |
| Abbott Laboratories | $1,199 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $764.02 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $649.74 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $379.72 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $280.72 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $245.92 | 13 | $0 (2024) |
| PFIZER INC. | $243.95 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.16 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $217.79 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,858 | 45 | Abbott Laboratories ($979.14) |
| 2023 | $862.12 | 44 | Novartis Pharmaceuticals Corporation ($208.97) |
| 2022 | $543.39 | 31 | Novartis Pharmaceuticals Corporation ($140.48) |
| 2021 | $934.10 | 53 | Janssen Pharmaceuticals, Inc ($269.55) |
| 2020 | $1,119 | 25 | Medtronic Vascular, Inc. ($625.74) |
| 2019 | $2,286 | 21 | Medtronic Vascular, Inc. ($2,087) |
| 2018 | $228.76 | 14 | ABIOMED ($73.07) |
| 2017 | $2,848 | 38 | Medtronic Vascular, Inc. ($2,423) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: GI | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $158.30 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $143.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $125.96 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $56.25 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: GI | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $248.96 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $237.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $124.18 | General |
| Category: Pacemakers | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,809 | 2,624 | $510,723 | $172,068 |
| 2022 | 31 | 1,911 | 2,560 | $547,854 | $185,434 |
| 2021 | 28 | 1,740 | 2,184 | $508,626 | $173,098 |
| 2020 | 29 | 1,607 | 2,116 | $490,530 | $163,741 |
Total Patients
7,067
Total Services
9,484
Medicare Billing
$694,341
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 330 | $76,467 | $29,365 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 121 | $37,510 | $16,268 | 43.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 147 | 251 | $38,905 | $15,634 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 93 | 138 | $30,774 | $12,730 | 41.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 77 | 81 | $35,154 | $11,173 | 31.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 196 | 198 | $44,154 | $10,368 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 60 | 62 | $29,202 | $9,112 | 31.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 25 | 25 | $27,775 | $8,580 | 30.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 19 | 19 | $22,306 | $7,668 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 96 | $14,976 | $5,833 | 39.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 86 | 252 | $18,648 | $5,327 | 28.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $10,800 | $4,065 | 37.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 86 | 246 | $16,236 | $4,035 | 24.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 24 | 24 | $5,712 | $3,918 | 68.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 259 | 348 | $14,616 | $3,638 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $11,715 | $3,623 | 30.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 22 | 85 | $10,200 | $3,609 | 35.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $10,608 | $3,550 | 33.5% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 12 | 12 | $9,000 | $2,488 | 27.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 27 | 30 | $7,110 | $2,457 | 34.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,785 | $2,382 | 35.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 20 | 21 | $11,235 | $1,802 | 16.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 29 | $5,684 | $1,436 | 25.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 18 | 19 | $2,508 | $1,189 | 47.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 19 | $1,615 | $749.17 | 46.4% |
About Dr. Deepak Patel, MD
Dr. Deepak Patel, MD is a Nuclear Cardiology healthcare provider based in Burleson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972551984.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Patel, MD has received a total of $10,679 in payments from pharmaceutical and medical device companies, with $1,858 received in 2024. These payments were reported across 271 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,838).
As a Medicare-enrolled provider, Patel has provided services to 7,067 Medicare beneficiaries, totaling 9,484 services with total Medicare billing of $694,341. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Burleson, TX
- Active Since 05/04/2006
- Last Updated 07/21/2022
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1972551984
Products in Payments
- AVEIR (Device) $979.14
- XARELTO (Drug) $649.74
- Micra (Device) $611.60
- LEQVIO (Drug) $391.79
- VERQUVO (Drug) $379.72
- ENTRESTO (Drug) $372.23
- Amplia MRI (Device) $350.50
- ELIQUIS (Drug) $313.48
- JARDIANCE (Drug) $229.16
- FARXIGA (Drug) $207.41
- MULTAQ (Drug) $202.86
- Arcalyst (Drug) $190.38
- LifeVest (Device) $175.47
- Impella (Device) $171.29
- NORTHERA (Drug) $136.12
- VYNDAQEL (Drug) $135.07
- MICRA (Device) $124.18
- Mitra Clip system (Device) $103.19
- Vascepa (Drug) $77.98
- Edarbi (Drug) $66.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.